We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serologic Characterization of Bone-healing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00377884
Recruitment Status : Withdrawn (Lack of patients, lack of funding for analysis)
First Posted : September 19, 2006
Last Update Posted : April 3, 2014
Sponsor:
Collaborator:
CCBR Clinical Research Center, Aalborg, Denmark
Information provided by:
Northern Orthopaedic Division, Denmark

Brief Summary:
Investigation of serologic bone markers in patients undergoing hip arthroplasty

Condition or disease Phase
Arthritis Phase 1

Detailed Description:
Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty
Study Start Date : January 2004
Primary Completion Date : June 2009
Estimated Study Completion Date : June 2009




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients planned for cementless THR for OA in the hip
Criteria

Inclusion Criteria:

  • Ages 40-80 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00377884


Locations
Denmark
Northern Orthopaedic Division
Aalborg, Northern Jutland, Denmark
Aalborg University Hospital
Aalborg, Denmark, 9000
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
CCBR Clinical Research Center, Aalborg, Denmark
Investigators
Principal Investigator: Mogens B Laursen, MD, Phd Northern Orthopaedic Division

Responsible Party: Northern Orthopaedic Division, Orthopaedic Research Unit, Aarhus University - Aalborg Hospital, Denmark
ClinicalTrials.gov Identifier: NCT00377884     History of Changes
Other Study ID Numbers: ON-04-018-MBL
First Posted: September 19, 2006    Key Record Dates
Last Update Posted: April 3, 2014
Last Verified: April 2014

Keywords provided by Northern Orthopaedic Division, Denmark:
THA